1. Home
  2. VERA vs HTH Comparison

VERA vs HTH Comparison

Compare VERA & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • HTH
  • Stock Information
  • Founded
  • VERA 2016
  • HTH 1998
  • Country
  • VERA United States
  • HTH United States
  • Employees
  • VERA N/A
  • HTH N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • HTH Major Banks
  • Sector
  • VERA Health Care
  • HTH Finance
  • Exchange
  • VERA Nasdaq
  • HTH Nasdaq
  • Market Cap
  • VERA 2.0B
  • HTH 1.9B
  • IPO Year
  • VERA 2021
  • HTH 2004
  • Fundamental
  • Price
  • VERA $23.82
  • HTH $30.77
  • Analyst Decision
  • VERA Buy
  • HTH Hold
  • Analyst Count
  • VERA 8
  • HTH 2
  • Target Price
  • VERA $64.63
  • HTH $33.00
  • AVG Volume (30 Days)
  • VERA 1.4M
  • HTH 468.9K
  • Earning Date
  • VERA 08-07-2025
  • HTH 07-24-2025
  • Dividend Yield
  • VERA N/A
  • HTH 2.33%
  • EPS Growth
  • VERA N/A
  • HTH 15.07
  • EPS
  • VERA N/A
  • HTH 1.97
  • Revenue
  • VERA N/A
  • HTH $1,208,822,000.00
  • Revenue This Year
  • VERA N/A
  • HTH N/A
  • Revenue Next Year
  • VERA N/A
  • HTH $1.36
  • P/E Ratio
  • VERA N/A
  • HTH $15.71
  • Revenue Growth
  • VERA N/A
  • HTH 2.13
  • 52 Week Low
  • VERA $18.53
  • HTH $26.67
  • 52 Week High
  • VERA $51.61
  • HTH $35.32
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.93
  • HTH 52.06
  • Support Level
  • VERA $22.57
  • HTH $30.92
  • Resistance Level
  • VERA $24.58
  • HTH $32.16
  • Average True Range (ATR)
  • VERA 1.22
  • HTH 0.53
  • MACD
  • VERA 0.14
  • HTH 0.04
  • Stochastic Oscillator
  • VERA 69.80
  • HTH 50.34

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About HTH Hilltop Holdings Inc.

Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.

Share on Social Networks: